#USA #UCB #Pleasanton #Vault CRM #Veeva

UCB Teams Up with Veeva for Enhanced Customer Engagement in Life Sciences

In a significant move to bolster its customer engagement strategies, UCB has officially chosen Veeva Systems' Vault CRM as its new engagement platform. This partnership marks a pivotal milestone in UCB's commitment to improving customer experiences across its operations in the life sciences sector.

Veeva Systems, a renowned name in the delivery of cloud-based solutions for the life sciences industry, announced this strategic partnership on November 4, 2026. The Vault CRM platform stands out for its use of industry-specific artificial intelligence, designed to streamline product launches and elevate customer interactions. Edwin Erckens, UCB's Chief Digital Technology Officer, expressed enthusiasm for this collaboration, emphasizing how it aligns with both companies' commitment to ensuring customer success. He stated, “We are excited to strengthen our strategic partnership with Veeva by moving to Vault CRM.” This move is expected to establish a robust technological foundation, aiding UCB in their commercial execution efforts.

Chris Moore, President of Veeva Europe, also reflected on the partnership, acknowledging the critical nature of the mission they are undertaking together. “Vault CRM will provide UCB with a stable, scalable, and future-ready technology foundation that will advance UCB's commercial strategy,” Moore noted. The collaboration aims to facilitate better efficiency and effectiveness in UCB's operations, ultimately improving the way the company serves its customers.

Vault CRM is a part of the broader Vault CRM Suite by Veeva, which is designed to support agentic commercial endeavors. One notable feature of Vault CRM is the Agentic Call Report, which generates commercial evidence to identify and address previously unrecognized barriers to treatment. This innovation is expected to equip UCB with better insights into the challenges faced by healthcare providers and patients, thereby enabling them to devise more targeted strategies to overcome these obstacles.

Veeva Systems has a strong reputation in the life sciences space, serving over 1,500 customers, which includes some of the world's largest pharmaceutical companies as well as emerging biotech firms. The company is deeply committed to innovation, product excellence, and achieving customer success. This ethos is further embodied in their structure as a Public Benefit Corporation, which illustrates their commitment to balancing the needs of diverse stakeholders, including customers, employees, and shareholders.

As UCB embarks on this new chapter with Veeva, the focus will remain on leveraging technology to enhance customer engagement and drive commercial success. As both companies work together towards this goal, the potential for enhanced patient outcomes and streamlined operations looks promising. For industry observers and stakeholders, this partnership signals a forward-thinking approach to customer engagement in life sciences, one that prioritizes the integration of advanced technology with customer insights to foster a more effective, outcome-driven engagement strategy.

For more information on this partnership and the innovative solutions provided by Veeva, interested parties can visit veeva.com.